Immunocore Holdings plc (IMCR)

Immunocore Holdings Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	442.63	402.47	297.36	162.15	92.46
Cash & Cash Equivalents	442.63	402.47	297.36	162.15	92.46
Cash Growth	9.98%	35.35%	83.39%	75.37%	-40.53%
Receivables	52.09	33.58	19.01	12.85	12.05
Inventory	4.5	0.69	0	0	0
Other Current Assets	29.6	37.23	12.04	16.17	50.85
Total Current Assets	528.82	473.98	328.41	191.16	155.35
Property, Plant & Equipment	42.74	38.78	39.42	47.03	69.34
Other Long-Term Assets	25.45	14.01	9.39	8.3	7.37
Total Long-Term Assets	68.18	52.79	48.81	55.33	76.71
Total Assets	597	526.76	377.22	246.49	232.06
Accounts Payable	17.8	14.45	44.3	32.16	36.88
Deferred Revenue	5.52	13	38.57	64.98	0
Current Debt	1.39	1.88	1.57	2.55	26.39
Other Current Liabilities	114.32	71.51	-7.96	-30.95	42.38
Total Current Liabilities	139.02	100.84	76.48	68.75	105.64
Long-Term Debt	82.64	79.57	78.23	77.31	47.87
Other Long-Term Liabilities	6.49	7.46	8.08	31.26	60.08
Total Long-Term Liabilities	89.14	87.02	86.31	108.56	107.96
Total Liabilities	228.16	187.86	162.78	177.31	213.6
Total Debt	84.03	81.45	79.8	79.86	74.26
Debt Growth	3.17%	2.07%	-0.08%	7.54%	214.69%
Retained Earnings	-744.67	-689.39	-601.74	-437.34	-348.88
Comprehensive Income	-36.26	-54.67	0.11	0.2	-0.04
Shareholders' Equity	368.84	338.9	214.43	69.18	18.46
Net Cash / Debt	358.59	321.02	217.56	82.29	18.2
Net Cash / Debt Growth	11.70%	47.55%	164.40%	352.15%	-86.20%
Net Cash Per Share	7.33	7.02	5.12	-	-
Working Capital	389.8	373.14	251.93	122.42	49.71
Book Value Per Share	7.54	7.41	5.05	1.70	0.45

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).